Psoriasis drug interaction study completed: what Hemay005 does to the body
NCT ID NCT06610890
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study involved 20 adults with psoriasis to see how Hemay005 tablets affect the way the body processes another drug called midazolam. Researchers also checked for heart rhythm changes and measured inflammation markers. The goal was to gather safety and drug interaction data, not to treat the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSORIASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China